ALEC
Price
$1.17
Change
+$0.01 (+0.86%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
116.92M
6 days until earnings call
EYEN
Price
$1.13
Change
+$0.04 (+3.67%)
Updated
Apr 24, 04:55 PM (EDT)
Capitalization
3.2M
19 days until earnings call
Ad is loading...

ALEC vs EYEN

Header iconALEC vs EYEN Comparison
Open Charts ALEC vs EYENBanner chart's image
Alector
Price$1.17
Change+$0.01 (+0.86%)
Volume$4.54K
Capitalization116.92M
Eyenovia
Price$1.13
Change+$0.04 (+3.67%)
Volume$1.6K
Capitalization3.2M
ALEC vs EYEN Comparison Chart
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. EYEN commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Buy and EYEN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ALEC: $1.18 vs. EYEN: $1.13)
Brand notoriety: ALEC and EYEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 71% vs. EYEN: 17%
Market capitalization -- ALEC: $116.92M vs. EYEN: $3.2M
ALEC [@Biotechnology] is valued at $116.92M. EYEN’s [@Biotechnology] market capitalization is $3.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileEYEN’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • EYEN’s FA Score: 1 green, 4 red.
According to our system of comparison, EYEN is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while EYEN’s TA Score has 4 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 4 bearish.
  • EYEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, EYEN is a better buy in the short-term than ALEC.

Price Growth

ALEC (@Biotechnology) experienced а +28.25% price change this week, while EYEN (@Biotechnology) price change was +4.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

ALEC is expected to report earnings on Jul 31, 2025.

EYEN is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALEC($117M) has a higher market cap than EYEN($3.2M). ALEC YTD gains are higher at: -37.566 vs. EYEN (-90.667). EYEN has higher annual earnings (EBITDA): -34.09M vs. ALEC (-136.16M). ALEC has more cash in the bank: 413M vs. EYEN (26.7M). EYEN has less debt than ALEC: EYEN (13M) vs ALEC (42.5M). ALEC has higher revenues than EYEN: ALEC (101M) vs EYEN (31.8K).
ALECEYENALEC / EYEN
Capitalization117M3.2M3,657%
EBITDA-136.16M-34.09M399%
Gain YTD-37.566-90.66741%
P/E RatioN/AN/A-
Revenue101M31.8K317,610%
Total Cash413M26.7M1,547%
Total Debt42.5M13M327%
FUNDAMENTALS RATINGS
ALEC vs EYEN: Fundamental Ratings
ALEC
EYEN
OUTLOOK RATING
1..100
2114
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9497
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EYEN's Valuation (22) in the Pharmaceuticals Major industry is in the same range as ALEC (54) in the Biotechnology industry. This means that EYEN’s stock grew similarly to ALEC’s over the last 12 months.

EYEN's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that EYEN’s stock grew similarly to ALEC’s over the last 12 months.

EYEN's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that EYEN’s stock grew similarly to ALEC’s over the last 12 months.

ALEC's Price Growth Rating (94) in the Biotechnology industry is in the same range as EYEN (97) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew similarly to EYEN’s over the last 12 months.

ALEC's P/E Growth Rating (92) in the Biotechnology industry is in the same range as EYEN (100) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew similarly to EYEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALECEYEN
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELUXY15.380.41
+2.74%
AB Electrolux
NUMIF0.03N/A
+2.00%
Numinus Wellness Inc.
RHHVF318.685.58
+1.78%
Roche Holding Ltd
DNBBY25.390.32
+1.26%
DNB ASA
ANGPY6.10-0.06
-0.97%
Anglo American Platinum Ltd.

EYEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYEN has been loosely correlated with CTXR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if EYEN jumps, then CTXR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYEN
1D Price
Change %
EYEN100%
+0.01%
CTXR - EYEN
45%
Loosely correlated
+2.67%
HALO - EYEN
36%
Loosely correlated
+0.34%
APM - EYEN
34%
Loosely correlated
+5.15%
VACBF - EYEN
32%
Poorly correlated
+26.68%
ALEC - EYEN
30%
Poorly correlated
+6.31%
More